Novartis ianalumab Phase III trial meets primary endpoint in immune thrombocytopenia Ruchika Sharma17 Aug 2025 2:00 PM ISTBasel: Novartis has announced positive top-line results from VAYHIT2, a Phase III trial evaluating ianalumab plus eltrombopag in patients with...
AbbVie announces USD 195 million investment to expand API manufacturing in US Ruchika Sharma17 Aug 2025 1:00 PM ISTNorth Chicago, Ill.: AbbVie has announced a USD 195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic...
Padcev plus Keytruda significantly improves survival for certain patients with bladder cancer when given before, after surgery: Pfizer Ruchika Sharma17 Aug 2025 10:30 AM ISTNew York: Pfizer Inc. and Astellas Pharma Inc. have announced positive topline results from the Phase 3 EV-303 clinical trial (also known as...
Novo Nordisk elevates Dr Gaurav Yadav as Cardiometabolic Medical Director for Business Area Africa Medical & Marketing team Ruchika Sharma16 Aug 2025 4:58 PM ISTNovo Nordisk has elevated Dr Gaurav Yadav as Cardiometabolic Medical Director for the Business Area Africa Medical & Marketing team.Sharing the...
Goa unveils lifesaving therapies pricing policy Ruchika Sharma16 Aug 2025 3:16 PM ISTPanaji: In a bold move set to transform healthcare access, the Goa government has launched pricing policy to make lifesaving therapies more...
Novo Nordisk Wegovy approved by USFDA for adults with noncirrhotic MASH with liver fibrosis Ruchika Sharma16 Aug 2025 12:45 PM ISTPlainsboro: Novo Nordisk has received approval from the US Food and Drug Administration (FDA) for a new indication for Wegovy...
Alembic Pharma gets USFDA nod for acne vulgaris cream Ruchika Sharma16 Aug 2025 11:54 AM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration...
Sanofi Rilzabrutinib earns orphan designation in EU for IgG4 related disease Ruchika Sharma15 Aug 2025 3:22 PM ISTParis: Sanofi has announced that the European Medicines Agency has granted orphan designation to rilzabrutinib, a reversible covalent...
Novo Nordisk Launches Wegovy in South Africa, Ramping Up Obesity Drug Battle with Eli Lilly Farhat Nasim15 Aug 2025 3:14 PM ISTJohannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and...
Lupin to Conduct BE Study for Synthetic Semaglutide Tablets in 3 Strengths Parthika Patel15 Aug 2025 3:02 PM ISTNew Delhi: Lupin Limited has received the green light from the Subject Expert Committee (SEC) under the Endocrinology & Metabolism division of the...
Sun Pharma Gets CDSCO Panel Nod for Active PMS of Fexuprazan Hydrochloride Tablets Susmita Roy15 Aug 2025 2:31 PM ISTNew Delhi: Sun Pharma Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...
Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio Ruchika Sharma15 Aug 2025 11:30 AM ISTHyderabad: Cohance Lifesciences, a global Contract Research, Development & Manufacturing Organization (CRDMO), has announced a strategic...
